VistaGen Therapeutics Inc (VTGN)

[Fress]

Their were dozens & dozens of companies working on vaccines for CV-19 that went up thousands of percentage points. I hit NVAX from under $10.00-high $200 hundreds. A handful working on fast acting low side effect depression & anxiety meds. between a third to half the population are dealing with depression & anxiety this is a HUGE un tapped market for second generation Depression & anxiety meds. First generations work about 30% of the time take months to kick into the blood stream and have massive side effects Thats where VTGN comes into play Boomage!!!!!!! massive roi from these levels. Jeffries just put out a $6-8 target this year for VTGN Multi billion market in the making..

VTGN is the only company that I'm aware of working on fast acting 15 min or less with very low side effects Second generation Depression & anxiety meds.

Phase 3 Ready

Multiple Phase 2's

World renown psychologists Michael Liebowitz heading VTGN trials is this very valuable resource to VTGN
https://ir.vistagen.com/press-releases/detail/98/vistagen-therapeutics-appoints-dr-michael-liebowitz-to-cns He developed the

Liebowitz scale he is heading all our trials for VTGN
https://nationalsocialanxietycenter.com/liebowitz-sa-scale/


including VistaGen PH94B Phase 2A Study Protocol for Treatment of Adjustment Disorder with Anxiety Related to the COVID-19 Pandemic through U.S. FDA's Coronavirus Treatment Acceleration Program (CTAP)

VTGN Institutional Shares have skyrocketed to 61% this year.From 7% last year


Biogen bets on depression drug in $1.5 billion deal with Sage Therapeutics.
https://www.reuters.com/article/us-biogen-sage/biogen-bets-on-depression-drug-in-1-5-billion-deal-with-sage-therapeutics-idUSKBN2871GU

From what i understand this company is being looked at by multiple big pharma companies in regards to being bought out Sage was just bought out VTGN has 14 indications in their pipeline for depression & anxiety meds.

VTGN pipeline
https://www.vistagen.com/pipeline


VTGN Biz presentation:
https://d1io3yog0oux5.cloudfront.net/_78f83b9b022497768da4a497c4d9e5b2/vistagen/db/241/816/pdf/VistaGen+Corporate+Presentation+Website+2020_11_16+250pm+PT.pdf

VTGN Twitter:
https://twitter.com/VistaGen?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor

Anxiety depression peers:
$CMPS 2 billion market cap early clinical trials. 190 million cash
$MMEDF 1.2 billion market cap.
$SAGE 3 Billion market cap bought out a few weeks ago for deperession anxiety pipeline.
$VTGN 333 million market cap Phase 3 ready. (nasdaq)
115 million in cash

$VTGN